Mutation mismatch repair gene deletions in diffuse large B-cell lymphoma

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous hematologic malignancy.
• Understanding the molecular drivers of DLBCL is crucial for targeted therapies.
• The role of DNA mismatch repair (MMR) in DLBCL pathogenesis is not fully elucidated.

Purpose of the Study:

• To investigate the role of microdeletions in DNA mismatch repair (MMR) pathway genes in DLBCL.
• To characterize the molecular consequences of MMR gene alterations in DLBCL.
• To explore the potential impact of MMR gene inactivation on DLBCL development.

Main Methods:

• High-resolution comparative genomic hybridization (CGH) on 70 DLBCL lymph node biopsies.
• Analysis of gene expression (PMS2, MSH2, MSH6) via quantitative PCR or similar methods.
• Somatic mutation profiling to assess mutational signatures and repair pathway fidelity.

Main Results:

• Identified microdeletions in MMR pathway genes (MSH2-MSH6, PMS2) in two DLBCL samples.
• Observed decreased or complete loss of MSH2-MSH6 and PMS2 gene expression.
• Detected aberrant hypermutation in one case without a typical activation-induced cytidine deaminase signature, suggesting a shift towards error-prone repair.

Conclusions:

• Inactivation of MMR pathway genes represents a potential pathogenic mechanism in a subset of DLBCL patients.
• The molecular mechanisms of MMR deficiency in these DLBCL cases differ from those in hereditary non-polyposis colorectal cancer or immunodeficiency-related lymphomas.
• These findings highlight the complexity of DNA repair pathway involvement in DLBCL and suggest distinct molecular subtypes.